Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid, Acute 1

Interventions

Tretinoin 27 Arsenic Trioxide 27 Cytarabine 20 Cyclophosphamide 14 Methotrexate 13 Idarubicin 13 Busulfan 11 Filgrastim 10 Etoposide 8 fludarabine phosphate 7 Peripheral Blood Stem Cell Transplantation 7 Mercaptopurine 7 Gemtuzumab 7 Daunorubicin 7 Radiotherapy 6 Tacrolimus 5 Mitoxantrone 5 Clofarabine 5 Vorinostat 4 Topotecan 4 Sorafenib 4 Antilymphocyte Serum 4 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3 Bortezomib 3 Azacitidine 3 venetoclax 2 tamibarotene 2 sargramostim 2 romidepsin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Promyelocytic, Acute × Arsenic × Clear all

NCT06982274 2025-05-30

IC-APL2020

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡